RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INKT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for MiNK Therapeutics, Inc. stock after losing 0.187%
(Updated on Mar 28, 2024)

Sell candidate since Mar 11, 2024 Loss -4.35% PDF

The MiNK Therapeutics, Inc. stock price fell by -0.187% on the last day (Thursday, 28th Mar 2024) from $0.91 to $0.91. During the last trading day the stock fluctuated 3.00% from a day low at $0.90 to a day high of $0.93. The price has fallen in 5 of the last 10 days but is still up by 2.06% over the past 2 weeks. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 35 thousand shares were bought and sold for approximately $31.77 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.80% during the next 3 months and, with a 90% probability hold a price between $0.734 and $0.88 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INKT Signals & Forecast

There are few to no technical positive signals at the moment. The MiNK Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.92. On a fall, the stock will find some support from the short-term average at $0.90. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, February 14, 2024, and so far it has fallen -9.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). MiNK Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for MiNK Therapeutics, Inc. stock

MiNK Therapeutics, Inc. finds support from accumulated volume at $0.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0271 between high and low, or 3.00%. For the last week, the stock has had daily average volatility of 3.89%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INKT) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect MiNK Therapeutics, Inc. to open at $0.91, and during the day (based on 14 day Average True Range), to move between $0.85 and $0.97, which gives a possible trading interval of +/-$0.0597 (+/-6.58%) up or down from last closing price. If MiNK Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.91 (0.19%) than the support at $0.89 (2.01%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is MiNK Therapeutics, Inc. stock A Buy?

MiNK Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.164 Sell Candidate Unchanged

Predicted Opening Price for MiNK Therapeutics, Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.91 ( 0.598%) $0.91

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INKT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.94 3.58 %
R2 0.93 2.44 %
R1 0.92 1.74 %
Current price: 0.91
Support S1 0.90 -0.542 %
S2 0.90 -1.25 %
S3 0.89 -2.39 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.99 9.01 %
R2 0.93 2.39 %
R1 0.91 0.187 %
Current price 0.91
Support S1 0.89 -2.01%
S2 0.89 -2.47%
S3 0.87 -4.22%

FAQ

What is the symbol for MiNK Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for MiNK Therapeutics, Inc. is INKT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MiNK Therapeutics, Inc. Stock?
MiNK Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy MiNK Therapeutics, Inc. Stock?
MiNK Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MiNK Therapeutics, Inc. Stock.

What's the current price of MiNK Therapeutics, Inc. Stock?
As of the end of day on the 2024-03-28, the price of an MiNK Therapeutics, Inc. (INKT) share was $0.91.

What is the 52-week high and low for MiNK Therapeutics, Inc. Stock?
The 52-week high for MiNK Therapeutics, Inc. Stock is $3.34 and the 52-week low is $0.750.

What is the market capitalization of MiNK Therapeutics, Inc. Stock?
As of the 2024-03-28, the market capitalization of MiNK Therapeutics, Inc. is 31.517M.

When is the next earnings date for MiNK Therapeutics, Inc.?
The upcoming earnings date for MiNK Therapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About MiNK Therapeutics, Inc.

MiNK Therapeutics. MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was former... INKT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT